Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

The purpose of this study was to evaluate by a retrospective analysis of 53 patients the efficacy of chemotherapy combining etoposide and cisplatin in the treatment of neuroendocrine tumours. The regimen was a combination of etoposide 100 mg m(–2) day(–1) for 3 days and cisplatin 100 mg m(–2) on day...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Mitry, E, Baudin, E, Ducreux, M, Sabourin, J-C, Rufié, P, Aparicio, T, Lasser, P, Elias, D, Duvillard, P, Schlumberger, M, Rougier, P
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 1999
Soggetti:
Regular Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362979/
https://ncbi.nlm.nih.gov/pubmed/10604732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690325
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi